SCHEMBL7013068

SCHEMBL7013068

N#CC1(NC(=O)C(C(N)=O)C2CCCCC2)CCNC1

nearest known ligand 0.48

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CTSS P25774 9/20 0.48
CTSL P07711 5/20 0.34
EPHX1 P07099 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7418337 0.91 CTSS (0.40) CTSSCTSLEPHX1
SCHEMBL7419722 0.80 CTSS (0.47) CTSSCTSL
SCHEMBL7417604 0.78 EPHX1 (0.33) CTSSCTSLEPHX1
SCHEMBL7675072 0.77 CTSS (0.42) CTSSCTSLEPHX1
SCHEMBL5363252 0.77 CTSS (0.60) CTSSCTSL
SCHEMBL23462315 0.73 CTSS (0.45) CTSSCTSLEPHX1
SCHEMBL6971904 0.69 CTSS (0.52) CTSSCTSL
SCHEMBL23462427 0.69 CTSS (0.42) CTSSCTSL
SCHEMBL8296552 0.69 CTSS (0.45) CTSSCTSL
Hydrochloric Acid SCHEMBL5367945 0.68 CTSS (0.51) CTSSCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2003529546-A 2003-10-07 JP claimed
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP claimed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO claimed
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP disclosed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO disclosed